TLDR Alopecia areata can be transferred through stem cell transplants from affected siblings.
The document reported cases of alopecia areata developing in patients after receiving allogeneic stem cell transplants (allo-SCT) from HLA-identical siblings who also had alopecia areata. Specifically, a 48-year-old man with chronic myeloid leukemia (CML) developed alopecia areata 15 months post-transplant, and a 55-year-old woman with acute myeloid leukemia (AML) developed the condition 16 months post-transplant. This suggested that alopecia areata could be transferred via T cells in the transplant from affected donors.
218 citations,
April 2012 in “British Journal of Dermatology” Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.
104 citations,
March 1987 in “Journal of The American Academy of Dermatology” Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.
4 citations,
August 2019 in “Journal of Dermatology” The conclusion is that balancing cost and carbon emissions in hybrid power systems is crucial, especially when high reliability is needed, but the model needs to consider all device efficiencies and distribution losses.
2 citations,
December 2018 in “Journal of cosmetic dermatology” Higher CRBP1 levels are linked to more severe alopecia areata.
52 citations,
March 2010 in “British Journal of Dermatology” Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.
Alopecia areata is an autoimmune disease that targets hair follicles.
5 citations,
June 1994 in “Journal of Cutaneous Pathology” No CD44 in alopecia areata, present in normal and androgenetic alopecia.
32 citations,
August 1984 in “Lancet”
